Subscribe To
VNDA / Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael H. Polymeropoulos on Q1 2022 Results - Earnings Call Transcript
Content Topics
Vanda
Pharmaceuticals
Inc
VNDA
Mihael
Polymeropoulos
2022
vnda
Results
Earnings
Transcript
Stock
VNDA News
By PRNewsWire
September 6, 2023
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
WASHINGTON , Sept. 6, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the more_horizontal
By The Motley Fool
September 5, 2023
Why Shares of Vanda Pharmaceuticals Are Dropping on Tuesday
Vanda is being dropped from the S&P 600 SmallCap 600. The company is suing the federal government over what it says was the release of trade secrets r more_horizontal
By Zacks Investment Research
September 1, 2023
After Plunging -7.98% in 4 Weeks, Here's Why the Trend Might Reverse for Vanda (VNDA)
The heavy selling pressure might have exhausted for Vanda (VNDA) as it is technically in oversold territory now. In addition to this technical measure more_horizontal
By PRNewsWire
April 27, 2023
Vanda Pharmaceuticals to Announce First Quarter 2023 Financial Results on May 3, 2023
Conference Call and Webcast to Follow WASHINGTON , April 27, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it more_horizontal
By Seeking Alpha
February 8, 2023
Vanda Pharmaceuticals Inc. (VNDA) Q4 2022 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA ) Q4 2022 Earnings Conference Call February 8, 2023 4:30 AM ET Company Participants Kevin Moran - CFO Mihael P more_horizontal
By PRNewsWire
February 1, 2023
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023
Conference Call and Webcast to Follow WASHINGTON , Feb. 1, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it w more_horizontal
By Seeking Alpha
November 2, 2022
Vanda Pharmaceuticals Inc. (VNDA) Q3 2022 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Kevin Moran - Senior Vice more_horizontal
By PRNewsWire
September 8, 2022
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
WASHINGTON , Sept. 8, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the company will participate in the more_horizontal
